|Bid||289.37 x 800|
|Ask||289.51 x 1000|
|Day's Range||289.17 - 294.62|
|52 Week Range||176.36 - 305.95|
|Beta (5Y Monthly)||0.49|
|PE Ratio (TTM)||27.60|
|Earnings Date||Oct 31, 2022 - Nov 04, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||298.01|
Vertex Pharmaceuicals flashed a buy signal last week on positive gene-editing news. It's one of several resilient stocks to watch in the bear market.
The Dow Jones Industrial Average dropped Friday on hot inflation data. Tesla stock fell ahead of the company's AI Day.
If you're not familiar with Vertex Pharmaceuticals (NASDAQ: VRTX), this healthcare stock is certainly one to put on your radar. The company develops and manufactures medicines that treat rare diseases. As of right now, it has four approved products, and all of them treat cystic fibrosis.